PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: dental hygienist

IN THIS ISSUE

Back to document page

1 IN THIS ISSUE Biosimilar Preferred Product Established for Rituximab ........................................ ......................... 4 Guidelines Established for Avalglucosidase alfa-ngpt (Nexviazyme) ........................................ ..... 4 Biosimilar Preferred Products Established for Pegfilgrastim ........................................ .................. 5 Guidelines Established for Eculizumab (Soliris) ........................................ ................................... 5 Coverage Guidelines Revised for Brentuximab Vedotin (Adcetris) ........................................ ........ 5 Coverage Guidelines Revised for Parathyroid Hormone (Natpara) ........................................ ........ 7 Policy Established for Anifrolumab-fnia (Saphnelo) ........................................ ................................ 8 New Criteria for Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors.

Highmark Blue Shield has established preferred product for rituximab. The preferred product for rheumatoid arthritis (RA) indications is rituximab- pvvr (Ruxience) when the clinical criteria within the policy are met. This revised Medical Policy will apply to professional providers and facility claims. The effective date is April 1, 2022.

  Medical, Blue, Shield, Highmark, Highmark blue shield

Download IN THIS ISSUE


Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Related search queries